88 related articles for article (PubMed ID: 25677850)
1. Evaluation of a possible role of Stigmatella aurantiaca ACE in Aβ peptide degradation: a molecular modeling approach.
Jalkute CB; Sonawane KD
J Mol Microbiol Biotechnol; 2015; 25(1):26-36. PubMed ID: 25677850
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling approach to explore the role of cathepsin B from Hordeum vulgare in the degradation of Aβ peptides.
Dhanavade MJ; Parulekar RS; Kamble SA; Sonawane KD
Mol Biosyst; 2016 Jan; 12(1):162-8. PubMed ID: 26568474
[TBL] [Abstract][Full Text] [Related]
3. Homology modeling, molecular docking and MD simulation studies to investigate role of cysteine protease from Xanthomonas campestris in degradation of Aβ peptide.
Dhanavade MJ; Jalkute CB; Barage SH; Sonawane KD
Comput Biol Med; 2013 Dec; 43(12):2063-70. PubMed ID: 24290922
[TBL] [Abstract][Full Text] [Related]
4. Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques.
Dhanavade MJ; Sonawane KD
Amino Acids; 2014 Aug; 46(8):1853-66. PubMed ID: 24729013
[TBL] [Abstract][Full Text] [Related]
5. N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.
Kugaevskaya EV; Veselovsky AV; Indeykina MI; Solovyeva NI; Zharkova MS; Popov IA; Nikolaev EN; Mantsyzov AB; Makarov AA; Kozin SA
Sci Rep; 2018 Jan; 8(1):298. PubMed ID: 29321566
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulation and molecular docking studies of Angiotensin converting enzyme with inhibitor lisinopril and amyloid Beta Peptide.
Jalkute CB; Barage SH; Dhanavade MJ; Sonawane KD
Protein J; 2013 Jun; 32(5):356-64. PubMed ID: 23660814
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.
Larmuth KM; Masuyer G; Douglas RG; Schwager SL; Acharya KR; Sturrock ED
FEBS J; 2016 Mar; 283(6):1060-76. PubMed ID: 26748546
[TBL] [Abstract][Full Text] [Related]
8. Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides.
Sun X; Becker M; Pankow K; Krause E; Ringling M; Beyermann M; Maul B; Walther T; Siems WE
Eur J Pharmacol; 2008 Jun; 588(1):18-25. PubMed ID: 18495113
[TBL] [Abstract][Full Text] [Related]
9. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
Chen PT; Chen CL; Lin LT; Lo CH; Hu CJ; Chen RP; Wang SS
PLoS One; 2016; 11(4):e0153360. PubMed ID: 27096746
[TBL] [Abstract][Full Text] [Related]
10. The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Toropygin IY; Kugaevskaya EV; Mirgorodskaya OA; Elisseeva YE; Kozmin YP; Popov IA; Nikolaev EN; Makarov AA; Kozin SA
Rapid Commun Mass Spectrom; 2008; 22(2):231-9. PubMed ID: 18085519
[TBL] [Abstract][Full Text] [Related]
11. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
[TBL] [Abstract][Full Text] [Related]
12. Metallostasis and amyloid β-degrading enzymes.
Grasso G; Giuffrida ML; Rizzarelli E
Metallomics; 2012 Aug; 4(9):937-49. PubMed ID: 22832870
[TBL] [Abstract][Full Text] [Related]
13. [Angiotensin converting enzyme and Alzheimer's disease].
Kugaevskaia EV
Biomed Khim; 2013; 59(1):5-24. PubMed ID: 23650720
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.
Zou K; Yamaguchi H; Akatsu H; Sakamoto T; Ko M; Mizoguchi K; Gong JS; Yu W; Yamamoto T; Kosaka K; Yanagisawa K; Michikawa M
J Neurosci; 2007 Aug; 27(32):8628-35. PubMed ID: 17687040
[TBL] [Abstract][Full Text] [Related]
15. [Angiotensin converting enzyme: the antigenic properties of the domain, role in Alzheimer's disease and tumor progression].
Kugaevskaya EV; Timoshenko OS; Solovyeva NI
Biomed Khim; 2015; 61(3):301-11. PubMed ID: 26215407
[TBL] [Abstract][Full Text] [Related]
16. Exploring mode of phosphoramidon and Aβ peptide binding to hECE-1 by molecular dynamics and docking studies.
Barage SH; Sonawane KD
Protein Pept Lett; 2014; 21(2):140-52. PubMed ID: 24000822
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
[TBL] [Abstract][Full Text] [Related]
18. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.
Hemming ML; Selkoe DJ
J Biol Chem; 2005 Nov; 280(45):37644-50. PubMed ID: 16154999
[TBL] [Abstract][Full Text] [Related]
19. Stimulating the Activity of Amyloid-Beta Degrading Enzymes: A Novel Approach for the Therapeutic Manipulation of Amyloid-Beta Levels.
Kuruppu S; Rajapakse NW; Spicer AJ; Parkington HC; Smith AI
J Alzheimers Dis; 2016 Oct; 54(3):891-895. PubMed ID: 27567865
[TBL] [Abstract][Full Text] [Related]
20. Structural significance of Neprylysin from Streptococcus suis GZ1 in the degradation of Aβ peptides, a causative agent in Alzheimer's disease.
Kamble S; Barale S; Dhanavade M; Sonawane K
Comput Biol Med; 2021 Sep; 136():104691. PubMed ID: 34343891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]